- Neoadjuvant Immunotherapy Combo Promising in Select Gastric/GEJ Cancers Medpage Today
- Zolbetuximab Plus mFOLFOX for CLDN18.2+/HER2- Advanced Gastric/GEJ Cancers Targeted Oncology
- Novel prognostic index to predict survival outcomes in gastric cancer patients Medical Xpress
- View Full Coverage on Google News
Source link